BICYCLE CONJUGATE FOR TREATING CANCER

(19)

(11)

EP 3 565 638 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	10.04.2024 Bulletin 2024/15

(45)	Mention of the grant of the patent:
	06.03.2024 Bulletin 2024/10

(21)	Application number: 18700385.0

(22)	Date of filing: 05.01.2018

(51)

International Patent Classification (IPC):

A61K 47/65^(2017.01)
A61K 47/64^(2017.01)
C07K 7/56^(2006.01)

A61P 35/00^(2006.01)
A61K 38/08^(2019.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 47/65; A61P 35/00; A61K 47/64; A61K 38/08; C07K 7/56

(86)	International application number:
	PCT/GB2018/050017

(87)	International publication number:
	WO 2018/127699 (12.07.2018 Gazette 2018/28)

(54)	BICYCLE CONJUGATE FOR TREATING CANCER BIZYKLISCHE KONJUGAT ZUR BEHANDLUNG VON KREBS CONJUGUÉ BICYCLIQUE POUR TRAITER LE CANCER

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

06.01.2017 US 201762443508 P

(43)	Date of publication of application:
	13.11.2019 Bulletin 2019/46

(73)	Proprietor: BicycleRD Limited
	Cambridge, CB21 6GS (GB)

(72)	Inventors:
	BENNETT, Gavin Cambridge, CB21 6GS (GB) TEUFEL, Daniel Paul Cambridge, CB21 6GS (GB)

(74)	Representative: J A Kemp LLP
	80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)

(56)

References cited: :

WO-A1-2010/089115
WO-A1-2016/067035

WO-A1-2013/050615
WO-A1-2017/191460

GU GUANGZHI ET AL: "The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells", BIOMATERIALS, vol. 34, no. 21, 2013, pages 5138-5148, XP028593827, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2013.03.036

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).